New sedative aims to make colonoscopy easier for IBD patients
NCT ID NCT07161297
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether remimazolam, a newer sedative, works as well as or better than midazolam for colonoscopy in 200 adults with inflammatory bowel disease (Crohn's or colitis). Participants get one of the two drugs plus fentanyl for pain, then rate their satisfaction and are checked for how quickly they recover. The goal is to see if remimazolam leads to a better experience and faster discharge.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Remimazolam (plus fentanyl)
- What this could lead to
- If remimazolam works better, it could make colonoscopy more comfortable and speed up recovery for people with IBD.
- What could go wrong
- This is a small, early-phase trial (200 people) comparing two sedatives, so it may not show a meaningful difference. Side effects like low oxygen levels are possible with any sedation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves vs. scope: a gentler way to spot pouch inflammation?
- Can a patient registry unlock the secrets of IBD?
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?